Overview
Switching between GLP-1 medications like semaglutide and liraglutide is a standard part of long-term weight management for many patients. While both medications work through similar metabolic pathways, understanding how your body adapts to a new clinical profile is essential for maintaining your progress. At ZipHealth, our US-licensed clinicians oversee every transition to ensure that your switch is medically appropriate and tailored to your specific health history.
Use this article if you want to:
Understand the metabolic similarities between semaglutide and liraglutide.
Learn how switching medications might impact your weight loss timeline.
Identify medical conditions that may prevent you from using liraglutide.
Know when and how to notify your clinician about changes in your health.
Will switching from Semaglutide to Liraglutide affect my progress or metabolism?
Both semaglutide and liraglutide belong to the same class of drugs (GLP-1 receptor agonists). They function similarly by slowing "gastric emptying" (how quickly food leaves your stomach) and signaling your brain to reduce appetite.
Because your body must adjust to a different active ingredient and a new dosing schedule, it is normal for your weight loss progress to pause or slow down temporarily during the transition. The primary difference you may notice is the strength of the appetite suppression and the daily (liraglutide) versus weekly (semaglutide) administration.
Should I consult my primary care physician before switching?
Yes. Any change in prescription medication should always be conducted under the direct supervision of a healthcare professional. You must consult with your ZipHealth prescriber before making any adjustments to your treatment plan. Additionally, we recommend informing your local primary care physician of the switch so they can maintain an accurate and comprehensive record of your current medications.
Is Liraglutide suitable for my medical history and weight loss goals?
Liraglutide is a safe and effective option for many, but it is not suitable for everyone. Specifically, it is not recommended for individuals with:
A personal or family history of medullary thyroid cancer (MTC).
Multiple Endocrine Neoplasia syndrome type 2 (MEN2).
Severe liver or kidney disease.
Type 1 diabetes.
Additionally, liraglutide should not be used if you are currently pregnant or breastfeeding. During your online consultation, our US-based medical team will carefully review your history to ensure liraglutide is a safe choice for your specific needs.
Important: Changes to Your Health Status
If you are already receiving treatment through ZipHealth and experience any changes in your medical history—such as a new diagnosis, new medication, or pregnancy—you must notify our team immediately. One of our practitioners will review the updated information to determine if it remains safe for you to continue your current treatment.
If you still need help after reviewing the information above, additional assistance is available.